TMDX vs. LIVN, ITGR, INMD, CNMD, OM, BLFS, MASI, BBIO, RVNC, and BEAM
Should you be buying TransMedics Group stock or one of its competitors? The main competitors of TransMedics Group include LivaNova (LIVN), Integer (ITGR), InMode (INMD), CONMED (CNMD), Outset Medical (OM), BioLife Solutions (BLFS), Masimo (MASI), BridgeBio Pharma (BBIO), Revance Therapeutics (RVNC), and Beam Therapeutics (BEAM). These companies are all part of the "medical" sector.
TransMedics Group vs.
TransMedics Group (NASDAQ:TMDX) and LivaNova (NASDAQ:LIVN) are both mid-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, community ranking, media sentiment, dividends, profitability, valuation and risk.
TransMedics Group has higher earnings, but lower revenue than LivaNova. TransMedics Group is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.
LivaNova received 294 more outperform votes than TransMedics Group when rated by MarketBeat users. Likewise, 69.57% of users gave LivaNova an outperform vote while only 53.24% of users gave TransMedics Group an outperform vote.
TransMedics Group has a beta of 1.45, meaning that its stock price is 45% more volatile than the S&P 500. Comparatively, LivaNova has a beta of 0.86, meaning that its stock price is 14% less volatile than the S&P 500.
TransMedics Group presently has a consensus price target of $72.29, indicating a potential downside of 8.03%. LivaNova has a consensus price target of $64.60, indicating a potential upside of 36.69%. Given LivaNova's higher probable upside, analysts clearly believe LivaNova is more favorable than TransMedics Group.
LivaNova has a net margin of -7.83% compared to TransMedics Group's net margin of -23.76%. LivaNova's return on equity of 10.40% beat TransMedics Group's return on equity.
In the previous week, TransMedics Group had 4 more articles in the media than LivaNova. MarketBeat recorded 9 mentions for TransMedics Group and 5 mentions for LivaNova. LivaNova's average media sentiment score of 0.96 beat TransMedics Group's score of 0.61 indicating that LivaNova is being referred to more favorably in the news media.
88.6% of TransMedics Group shares are owned by institutional investors. Comparatively, 98.9% of LivaNova shares are owned by institutional investors. 6.7% of TransMedics Group shares are owned by company insiders. Comparatively, 0.2% of LivaNova shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Summary
LivaNova beats TransMedics Group on 10 of the 18 factors compared between the two stocks.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding TMDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
TransMedics Group Competitors List
Related Companies and Tools
